[Serum I-125 insulin IgG binding capacity in diabetic patients on a long-term insulin treatment, with reference to indications for monocomponent insulin therapy].
D000293:Adolescent; D000917:Antibody Formation; D001665:Binding Sites; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy* / Q000276:immunology; D005500:Follow-Up Studies; D006801:Humans; D007122:Immunoelectrophoresis; D007074:Immunoglobulin G; D007328:Insulin / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D049528:Insulin, Long-Acting / Q000008:administration & dosage; D011863:Radioimmunoassay; D013997:Time Factors
D007074:Immunoglobulin G; D007328:Insulin; D049528:Insulin, Long-Acting
Capacità fissante delle IgG seriche per i'insulina 125I nei diabetici a lungo insulinizzati, in riferimento alle indicazioni per il trattamento con insuline monocomponenti.